Add this topic to your myFT Digest for news straight to your inbox
US drugmaker and French partner begin late-stage trial with 14% of global population showing evidence of infection
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
French biotech group is hoping that jab-hesitant will decide to take its offering
French group’s shares soar as bloc agrees to buy up to 60m doses over two years
Trial results come month after UK terminated contract with French company
Several pharma groups are hoping the Covid vaccine race will turn out to be a marathon, not a sprint
Doses were to be manufactured in Scotland with deliveries starting in 2022
French group sets out price range after promising early trials for Covid-19 jab
Paris-listed Valneva is seeking to raise $100m in American depositary shares
Biotech company’s jab could be used to tackle Covid-19 virus variants
UK agrees to buy potential coronavirus inoculations from BioNTech and Valneva
International Edition